{"schema":"qazvision-content-revisions/v1","entity":{"type":"atom","code":"AKR-2025-1217-GLAVANAGRA-B-001","history_url":"https://qaz.vision/api/revisions/atom/AKR-2025-1217-GLAVANAGRA-B-001.json"},"verification":{"hash_algorithm":"sha256","chain":"previous_hash points to the preceding content_hash for this entity","payload_included":false},"revision_count":2,"limit":20,"current":{"id":17347,"entity_type":"atom","entity_id":4876,"entity_code":"AKR-2025-1217-GLAVANAGRA-B-001","revision_number":2,"operation":"baseline","public_state":"published","content_hash":"f4c915a1728974f8f726c93fde16b5969db8cf2a068fd8ab05f8dc5a291d216f","previous_hash":"3d6e745e261df0b9aa88b39148f9bb50fbf6e246cc7f91aaa1b9a739c4382f20","created_at":"2026-07-14T05:09:35.112774Z","canonical_url":"https://qaz.vision/dokument/677"},"revisions":[{"id":17347,"entity_type":"atom","entity_id":4876,"entity_code":"AKR-2025-1217-GLAVANAGRA-B-001","revision_number":2,"operation":"baseline","public_state":"published","content_hash":"f4c915a1728974f8f726c93fde16b5969db8cf2a068fd8ab05f8dc5a291d216f","previous_hash":"3d6e745e261df0b9aa88b39148f9bb50fbf6e246cc7f91aaa1b9a739c4382f20","created_at":"2026-07-14T05:09:35.112774Z","canonical_url":"https://qaz.vision/dokument/677"},{"id":6778,"entity_type":"atom","entity_id":4876,"entity_code":"AKR-2025-1217-GLAVANAGRA-B-001","revision_number":1,"operation":"baseline","public_state":"published","content_hash":"3d6e745e261df0b9aa88b39148f9bb50fbf6e246cc7f91aaa1b9a739c4382f20","previous_hash":null,"created_at":"2026-07-13T18:08:51.405942Z","canonical_url":"https://qaz.vision/dokument/677"}]}